Search

Your search keyword '"van den Berg, Victor J."' showing total 7 results
Start Over Author "van den Berg, Victor J." Publication Year Range Last 3 years
7 results on '"van den Berg, Victor J."'

1. Potential role of left atrial strain in estimation of left atrial pressure in patients with chronic heart failure

Author

Aga, Yaar S., primary, Abou Kamar, Sabrina, additional, Chin, Jie Fen, additional, van den Berg, Victor. J., additional, Strachinaru, Mihai, additional, Bowen, Daniel, additional, Frowijn, Rene, additional, Akkerhuis, Martijn K., additional, Constantinescu, Alina A., additional, Umans, Victor, additional, Geleijnse, Marcel L., additional, Boersma, Eric, additional, Brugts, Jasper J., additional, Kardys, Isabella, additional, and van Dalen, Bas M., additional

Published
2023
Full Text
View/download PDF

2. Prognostic value of temporal patterns of global longitudinal strain in patients with chronic heart failure

Author

Abou Kamar, Sabrina, primary, Aga, Yaar S., additional, de Bakker, Marie, additional, van den Berg, Victor J., additional, Strachinaru, Mihai, additional, Bowen, Dan, additional, Frowijn, René, additional, Akkerhuis, K. Martijn, additional, Brugts, Jasper, additional, Manintveld, Olivier, additional, Umans, Victor, additional, Geleijnse, Marcel L., additional, Boersma, Eric, additional, van Dalen, Bas M., additional, and Kardys, Isabella, additional

Published
2023
Full Text
View/download PDF

3. Persistently elevated levels of sST2 after acute coronary syndrome are associated with recurrent cardiac events

Author

van den Berg, Victor. J., Vroegindewey, Maxime M., Umans, Victor A., van der Harst, Pim, Asselbergs, Folkert W., Akkerhuis, K. Martijn, Kardys, Isabella, Boersma, Eric, Cardiovascular Centre (CVC), and Cardiology

Subjects
Male, sST2, RISK, NT-PROBNP, Health, Toxicology and Mutagenesis, Clinical Biochemistry, Middle Aged, Prognosis, Interleukin-1 Receptor-Like 1 Protein, Biochemistry, C-REACTIVE PROTEIN, acute coronary syndrome, SDG 3 - Good Health and Well-being, MYOCARDIAL-INFARCTION, MANAGEMENT, IL-33, Humans, atherosclerosis, repeated measurements, SOLUBLE ST2, Biomarkers, secondary prevention, Proportional Hazards Models
Abstract

Purpose: Higher soluble ST2 (sST2) levels at admission are associated with adverse outcome in acute coronary syndrome (ACS) patients. We studied the dynamics of sST2 over time in post-ACS patients prior to a recurrent ACS or cardiac death. Methods: We used the BIOMArCS case cohort, consisting of 187 patients who underwent serial blood sampling during one-year follow-up post-ACS. sST2 was batch-wise quantified after completion of follow-up in a median of 8 (IQR: 5–11) samples per patient. Joint modelling was used to investigate the association between longitudinally measured sST2 and the endpoint, adjusted for gender, GRACE risk score and history of cardiovascular diseases. Results: Median age was 64 years and 79% were men. The 36 endpoint patients had systematically higher sST2 levels than those that remained endpoint free (mean value 29.6 ng/ml versus 33.7 ng/ml, p-value 0.052). The adjusted hazard ratio for the endpoint per standard deviation increase of sST2 was 1.64 (95% confidence interval: 1.09–2.34; p = 0.019) at any time point. We could not identify a steady or sudden increase of sST2 in the run-up to the combined endpoint. Conclusion: Asymptomatic post-ACS patients with persistently higher sST2 levels are at higher risk of recurrent ACS or cardiac death during one-year follow-up.

Published
2022

4. IGF-1 is not related to long-term outcome in hyperglycemic acute coronary syndrome patients

Author

Iswandi, Cindya P, primary, van den Berg, Victor J, additional, Simsek, Suat, additional, Velzen, Daan van, additional, Boekel, Edwin Ten, additional, Cornel, Jan-Hein, additional, Boer, Sanneke de, additional, Mulder, Maarten de, additional, Akkerhuis, K Martijn, additional, Boersma, Eric, additional, Umans, Victor A, additional, and Kardys, Isabella, additional

Published
2021
Full Text
View/download PDF

6. Persistently elevated levels of sST2 after acute coronary syndrome are associated with recurrent cardiac events.

Author

van den Berg VJ, Vroegindewey MM, Umans VA, van der Harst P, Asselbergs FW, Akkerhuis KM, Kardys I, and Boersma E

Subjects
Biomarkers, Humans, Interleukin-1 Receptor-Like 1 Protein, Male, Middle Aged, Prognosis, Proportional Hazards Models, Acute Coronary Syndrome diagnosis
Abstract

Purpose: Higher soluble ST2 (sST2) levels at admission are associated with adverse outcome in acute coronary syndrome (ACS) patients. We studied the dynamics of sST2 over time in post-ACS patients prior to a recurrent ACS or cardiac death., Methods: We used the BIOMArCS case cohort, consisting of 187 patients who underwent serial blood sampling during one-year follow-up post-ACS. sST2 was batch-wise quantified after completion of follow-up in a median of 8 (IQR: 5-11) samples per patient. Joint modelling was used to investigate the association between longitudinally measured sST2 and the endpoint, adjusted for gender, GRACE risk score and history of cardiovascular diseases., Results: Median age was 64 years and 79% were men. The 36 endpoint patients had systematically higher sST2 levels than those that remained endpoint free (mean value 29.6 ng/ml versus 33.7 ng/ml, p-value 0.052). The adjusted hazard ratio for the endpoint per standard deviation increase of sST2 was 1.64 (95% confidence interval: 1.09-2.34; p  = 0.019) at any time point. We could not identify a steady or sudden increase of sST2 in the run-up to the combined endpoint., Conclusion: Asymptomatic post-ACS patients with persistently higher sST2 levels are at higher risk of recurrent ACS or cardiac death during one-year follow-up.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results